Comparing the Metabolic, Systemic, and Neuropsychiatric Impacts of Olanzapine and Clozapine in Patients with Schizophrenia.

Pharmaceuticals (Basel) · 2025 · PMC12472767 · PMID 41011185

Europe PMC DOI

hedged sentence

0.3250

closest p · 6.5× alpha

0.3250

boldest claim

The sentences

did not reach statistical significancep = 0.325not close (p > 0.1)

Moreover, although the effect was more prominent in the OLZ-treated group, it did not reach statistical significance ( p = 0.325) when compared with that in the CLZ-treated group. 2.8.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.